Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Long-term Benefit of Lecanemab in Patients with Low Baseline Amyloid: Estimation of Time Saved

Author:Dickson, Samuel   Whetten, John   Hendrix, Suzanne   Youmans-Kidder, Katherine   Jones, Daryl   

Session Name:P2: Aging, Dementia, and Behavioral Neurology: Alzheimer's Disease and Anti-amyloid Therapies 2  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P2.003  

Author Institution:Pentara Corporation, Millcreek, UT  Eisai Inc., Chicago, IL  Eisai Inc., Nutley, NJ  

E2086, a Selective Orexin Receptor Two Agonist: Study for Promoting Wakefulness in Patients With Narcolepsy Type One

Author:Corser, Bruce   Cheng, Jocelyn   Hall, Nancy   Rawal, Sumit   Moline, Margaret   

Session Name:P6: Sleep: Disorders of Excessive Daytime Somnolence  

Topic:Sleep  

Program Number:P6.003  

Author Institution:Sleep Management Institute, OH  Eisai Inc., Nutley, NJ  

Interpreting Adverse Events of Somnolence With Lemborexant in Clinical Trials

Author:Moline, Margaret   Reaume, Christopher J.   Kumar, Dinesh   Pinner, Kate   Swainson, Jennifer   

Session Name:P6: Sleep: Disorders of Excessive Daytime Somnolence  

Topic:Sleep  

Program Number:P6.012  

Author Institution:Eisai Inc., Ridgefield Park, NJ  Eisai Inc., NJ  Eisai Inc., Nutley, NJ  Eisai, Ltd., Hatfield, United Kingdom  University of Alberta, Edmonton, AB, Canada